The AML Global Portal were delighted to speak to Jacqueline Cloos, VU University Medical Center, Amsterdam, NL, during the European School of Hematology (ESH) Translational Research Conference on AML. We asked Jacqueline Cloos: What's new in flow cytometry assessment of MRD? She discusses how clinically validated MRD can be improved to act as a surrogate end-point in clinical trials.
ESH 2019 | What's new in flow cytometry assessment of MRD?
Was this article informative? Thank you for your feedback!100% of people found this article informative